Vertical transmission of HPV in pregnancy A prospective clinical study of HPV-positive pregnant women

被引:0
|
作者
Jach, Robert [1 ]
Galarowicz, Bartlomiej [1 ]
Hurasl, Hubert [1 ]
Pawlik, Dorota [2 ]
Basta, Tomasz [1 ]
Streb, Joanna [1 ]
Wolski, Hubert [1 ]
Ludwin, Artur [1 ]
Ludwin, Inga [1 ]
机构
[1] Jagiellonian Univ, Coll Med, Dept Gynecol & Oncol, PL-31501 Krakow, Poland
[2] Jagiellonian Univ, Coll Med, Dept Neonatol, PL-31501 Krakow, Poland
关键词
HPV; pregnancy; neonate; vertical transmission; CRP; HUMAN-PAPILLOMAVIRUS INFECTION; PERINATAL TRANSMISSION; NEWBORNS; CANCER; POPULATION; DELIVERY; MOTHERS; SPAIN; RISK;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction: Human papillomavirus (HPV) is the most common sexually transmitted infection. Data reporting vertical transmission of HPV from the mother to the fetus are inconsistent and scant. Vertical transmission may occur by hematogenic route (transplacental), or by ascending contamination, or through the birth canal, which may result in the dreaded and rare laryngeal papillomatosis. Infected sperm at fertilization is a potential route of infection, too. Objective: The objective of the study was to evaluate the rate of vertical transmission of HPV in HPV-positive pregnant women to their newborn infants, as well as the risk factors of HPV vertical transmission. Material and methods: The clinical material was provided by 136 pregnant women, aged 18-45 years. Out of this group, 30 (22.05%) women with abnormal Pap test and positive DNA HPV test were prospectively observed. Neonatal status, i.e. DNA HPV from the nasopharyngeal smear, was recorded in all infants during the perinatal period. The conventional Pap test was performed with the cervix brush in all women. The Bethesda 2011 classification system was applied. Results: An average C Reactive Protein (CRP) concentration in the studied pregnant women was 11.6083 (Std Dev - 12.93). The most frequent cytological findings in the cervical smears from the examined women were AS-GUS, n=13 (43.3%), then - LSIL, n=10 (33.3%), HSIL- n=5 (16.7%) and AGC - n=2 (6.7%). In the neonates, the presence of LR HPV DNA was detected in 9 cases (30.0%) and HR HPV DNA in 7 cases (23.3%). Fourteen neonates (46.7%) tested HPV DNA negative in the perinatal period. Conclusions: HPV infection (incidental or chronic) is observed in approximately 22% of pregnant women from the Matopolska province. Neonatal HPV infection in HPV-positive women was observed in 53.3% of the subjects. CRP concentration > 10 mg/dl in the serum of pregnant women statistically significantly (p 0.001) reduces the risk of vertical transmission of HPV from the mother to the fetus.
引用
收藏
页码:672 / 676
页数:5
相关论文
共 50 条
  • [41] HPV-Positive Oropharyngeal Cancer Via p16 Immunohistochemistry in Japan
    Toman, Julia
    Von Larson, Scott
    Umeno, Hirohito
    Kurita, Takashi
    Furusaka, Tohru
    Hasegawa, Hisashi
    Prasad, Manju L.
    Sasaki, Clarence T.
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2017, 126 (02) : 152 - 158
  • [42] Bacterial Vaginosis and Inflammatory Response Showed Association with Severity of Cervical Neoplasia in HPV-Positive Women
    de Castro-Sobrinho, Jucara Maria
    Rabelo-Santos, Silvia Helena
    Fugueiredo-Alves, Rosane Ribeiro
    Derchain, Sophie
    Sarian, Luis Otavio Z.
    Pitta, Denise R.
    Campos, Elisabete A.
    Zeferino, Luiz Carlos
    DIAGNOSTIC CYTOPATHOLOGY, 2016, 44 (02) : 80 - 86
  • [43] A Review on Inosine Pranobex Immunotherapy for Cervical HPV-Positive Patients
    Kovachev, Stefan Miladinov
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 2039 - 2049
  • [44] HPV clearance in postpartum period of HIV-positive and negative women: a prospective follow-up study
    Jalil, Emilia Moreira
    Bastos, Francisco Inacio
    dos Santos Melli, Patricia Pereira
    Duarte, Geraldo
    Simoes, Renata Toscano
    Yamamoto, Aparecida Yulie
    Amaral de Morais, Rodrigo Augustus
    Quintana, Silvana Maria
    BMC INFECTIOUS DISEASES, 2013, 13
  • [45] Risk of residual/recurrent cervical diseases in HPV-positive women post-conization depends on HPV integration status
    Lin, Wenyu
    Huang, Yuxuan
    Zhang, Yan
    Huang, Lixiang
    Cai, Hongning
    Huang, Guanxiang
    Li, Ye
    Zhang, Qiaoyu
    Xue, Huifeng
    Dong, Binhua
    Sun, Pengming
    INFECTIOUS AGENTS AND CANCER, 2025, 20 (01):
  • [46] The use of colposcopy for triage in HPV-positive women aged 65 years and older
    Kuenkel, E.
    Jaeger, A.
    Bohlmann, I.
    Bergauer, F.
    Kuehler-Obbarius, C.
    Prieske, K.
    Maass-Poppenhusen, K.
    Schmalfeldt, B.
    Woelber, L.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2024, 309 (04) : 1561 - 1567
  • [47] Cytology Triage for HPV-Positive Postmenopausal Women in a Setting of Cervical Cancer Screening
    Chacko, Aparna
    Bidkar, Vishaka C.
    Acharya, Geeta
    Crasta, Julian
    DIAGNOSTIC CYTOPATHOLOGY, 2025, 53 (05) : 246 - 250
  • [48] Whole genome sequencing reveals complexity in both HPV sequences present and HPV integrations in HPV-positive oropharyngeal squamous cell carcinomas
    Gao, Ge
    Wang, Jintu
    Kasperbauer, Jan L.
    Tombers, Nicole M.
    Teng, Fei
    Gou, Honglan
    Zhao, Yonggang
    Bao, Zhenhong
    Smith, David, I
    BMC CANCER, 2019, 19 (1)
  • [49] Current landscape of clinical trials for HPV-positive head and neck squamous cell carcinoma (HNSCC)
    Bteich, Yara T.
    Hosri, Jad E.
    Wehbi, Jad A.
    Daou, Lea R.
    ECANCERMEDICALSCIENCE, 2022, 16
  • [50] Understanding HPV-positive women's needs and experiences in relation to patient-provider communication issues: a qualitative study
    Qaderi, Kowsar
    Geranmayeh, Mehrnaz
    Farnam, Farnaz
    Hasani, Shahrzad Sheikh
    Mirmolaei, Seyedeh Tahereh
    BMC HEALTH SERVICES RESEARCH, 2021, 21 (01)